» Articles » PMID: 37998584

Detectability and Volumetric Accuracy of Pulmonary Nodules in Low-Dose Photon-Counting Detector Computed Tomography: An Anthropomorphic Phantom Study

Abstract

The aim of this phantom study was to assess the detectability and volumetric accuracy of pulmonary nodules on photon-counting detector CT (PCD-CT) at different low-dose levels compared to conventional energy-integrating detector CT (EID-CT). In-house fabricated artificial nodules of different shapes (spherical, lobulated, spiculated), sizes (2.5-10 mm and 5-1222 mm), and densities (-330 HU and 100 HU) were randomly inserted into an anthropomorphic thorax phantom. The phantom was scanned with a low-dose chest protocol with PCD-CT and EID-CT, in which the dose with PCD-CT was lowered from 100% to 10% with respect to the EID-CT reference dose. Two blinded observers independently assessed the CT examinations of the nodules. A third observer measured the nodule volumes using commercial software. The influence of the scanner type, dose, observer, physical nodule volume, shape, and density on the detectability and volumetric accuracy was assessed by a multivariable regression analysis. In 120 CT examinations, 642 nodules were present. Observer 1 and 2 detected 367 (57%) and 289 nodules (45%), respectively. With PCD-CT and EID-CT, the nodule detectability was similar. The physical nodule volumes were underestimated by 20% (range 8-52%) with PCD-CT and 24% (range 9-52%) with EID-CT. With PCD-CT, no significant decrease in the detectability and volumetric accuracy was found at dose reductions down to 10% of the reference dose ( > 0.05). The detectability and volumetric accuracy were significantly influenced by the observer, nodule volume, and a spiculated nodule shape ( < 0.05), but not by dose, CT scanner type, and nodule density ( > 0.05). Low-dose PCD-CT demonstrates potential to detect and assess the volumes of pulmonary nodules, even with a radiation dose reduction of up to 90%.

Citing Articles

Detection, measurement, and diagnosis of lung nodules by ultra-low-dose CT in lung cancer screening: a systematic review.

Pan Z, Zhang Y, Zhang L, Wang L, Zhao K, Li Q BJR Open. 2024; 6(1):tzae041.

PMID: 39665102 PMC: 11634541. DOI: 10.1093/bjro/tzae041.

References
1.
Perez S, Marshall N, Struelens L, Bosmans H . Characterization and validation of the thorax phantom Lungman for dose assessment in chest radiography optimization studies. J Med Imaging (Bellingham). 2018; 5(1):013504. PMC: 5800460. DOI: 10.1117/1.JMI.5.1.013504. View

2.
Si-Mohamed S, Miailhes J, Rodesch P, Boccalini S, Lacombe H, Leitman V . Spectral Photon-Counting CT Technology in Chest Imaging. J Clin Med. 2021; 10(24). PMC: 8704215. DOI: 10.3390/jcm10245757. View

3.
Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel C . European position statement on lung cancer screening. Lancet Oncol. 2017; 18(12):e754-e766. DOI: 10.1016/S1470-2045(17)30861-6. View

4.
Dunning C, Marsh Jr J, Winfree T, Rajendran K, Leng S, Levin D . Accuracy of Nodule Volume and Airway Wall Thickness Measurement Using Low-Dose Chest CT on a Photon-Counting Detector CT Scanner. Invest Radiol. 2022; 58(4):283-292. PMC: 10023282. DOI: 10.1097/RLI.0000000000000933. View

5.
Manser R, Lethaby A, Irving L, Stone C, Byrnes G, Abramson M . Screening for lung cancer. Cochrane Database Syst Rev. 2013; (6):CD001991. PMC: 6464996. DOI: 10.1002/14651858.CD001991.pub3. View